Skip to main content

Treatment of insufficient lactation is often not evidence-based

Paul Bryde Axelsson1, Flemming Bjerrum2 & Ellen Christine Leth Løkkegaard1

21. jul. 2014
2 min.

INTRODUCTION

Breast milk has many advantages over formula for infants in developed and developing countries alike. Despite intentions of breastfeeding, some women develop insufficient lactation. Treatment options traditionally include breastfeeding education and pharmacotherapy.

MATERIAL AND METHODS

An electronic questionnaire regarding treatment of insufficient lactation was sent to all obstetric departments (n = 21) and neonatal wards (n = 17) in Denmark. Three main questions were included which focused on: breastfeeding education for women, use of pharmacotherapy and availability of local guidelines.

RESULTS

In all, 30 out of a total of 38 departments participated; and of those, 93% offered some form of breastfeeding education. 50% used either metoclopramide or syntocinon to promote lactation. None used domperidone. 73% had a local clinical guideline. 77% offered sessions with a lactation consultant.

CONCLUSION

Despite lack of evidence, half of the Danish obstetric departments and neonatal wards use metoclopramide and syntocinon for insufficient lactation. Domperidone might provide an alternative, but no departments reported its use. Management of insufficient lactation should always be initiated by counselling and education. Only when these treatment options are exhausted should pharmacotherapy with a suitable medication be considered.

FUNDING

Not relevant.

TRIAL REGISTRATION

Not relevant.

CORRESPONDENCE: Paul Bryde Axelsson. E-mail: paulbryde@gmail.com

CONFLICTS OF INTEREST: none. Disclosure forms provided by the authors are available with the full text of this article at www.danmedj.dk

REFERENCE: Dan Med J 2014;61(7):A4869